Net Margin - Vicore Pharma Holding AB (STO:VICO) - Alpha Spread

Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.12 SEK -0.7% Market Closed
Market Cap: 795.5m SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Net Margin
Vicore Pharma Holding AB

-191.9%
Current
-30%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-191.9%
=
Net Income
-200.1m
/
Revenue
104.2m

Net Margin Across Competitors

Country SE
Market Cap 795.5m SEK
Net Margin
-192%
Country US
Market Cap 341.9B USD
Net Margin
10%
Country US
Market Cap 180.5B USD
Net Margin
10%
Country US
Market Cap 127.8B USD
Net Margin
32%
Country US
Market Cap 123.3B USD
Net Margin
-5%
Country US
Market Cap 104.5B USD
Net Margin
4%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.4B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for Vicore Pharma Holding AB.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-191.9%
=
Net Income
-200.1m
/
Revenue
104.2m
What is the Net Margin of Vicore Pharma Holding AB?

Based on Vicore Pharma Holding AB's most recent financial statements, the company has Net Margin of -191.9%.